TASTYLIA ORAL JELLY

What is TASTYLIA ORAL JELLY?

TASTYLIA ORAL JELLY is a modern drug in the form of an oral jelly designed for the correction of erectile dysfunction in men. The main active substance of the preparation is tadalafil, which belongs to the pharmacological group of phosphodiesterase type 5 (PDE-5) inhibitors. The manufacturer of TASTYLIA ORAL JELLY is the Indian pharmaceutical company Healing Pharma, which specializes in the production of high-quality generics in accordance with international GMP standards. The oral jelly form provides faster absorption of the active component compared to traditional tablets, as the drug begins to act already in the oral cavity. Thanks to this, a reduction in the waiting time for the effect and convenience of use in any conditions are achieved.

TASTYLIA ORAL JELLY is positioned as a therapeutic agent for restoring natural erectile function, rather than as a sexual desire stimulant. This means that sexual stimulation is necessary to achieve the effect, since the mechanism of action of the drug is aimed at enhancing the body's physiological response to natural arousal. Tadalafil in TASTYLIA ORAL JELLY provides a long-lasting therapeutic effect that can persist for up to 36 hours after a single dose. Such prolonged action favorably distinguishes the drug from other representatives of the PDE-5 inhibitor group and allows patients not to tie medication intake to a specific moment of intimacy. In addition, the oral jelly has a pleasant taste, which facilitates administration for patients who experience discomfort when swallowing solid dosage forms.

Healing Pharma manufactures TASTYLIA ORAL JELLY using a highly purified tadalafil substance, ensuring stable bioavailability and a predictable clinical outcome. Each sachet contains a precisely measured dose of the active component, eliminating the risk of dosing errors. The drug has passed the necessary clinical trials for bioequivalence to the original agent, confirming its therapeutic efficacy and safety. The release form in the form of single-use sachets ensures hygiene and ease of transportation, as well as protection of the active component from exposure to moisture and light. TASTYLIA ORAL JELLY belongs to the prescription group of drugs, so its use should take place after consultation with a doctor.

What is TASTYLIA ORAL JELLY prescribed for?

The main indication for the use of TASTYLIA ORAL JELLY is erectile dysfunction — a condition in which a man cannot achieve or maintain an erection sufficient for satisfactory sexual intercourse. This disorder can have various etiologies: psychogenic, organic, or mixed, and the drug acts effectively regardless of the cause of dysfunction development. Tadalafil restores the impaired erectile response by relaxing the smooth muscle of the penile blood vessels and increasing blood flow to the cavernous bodies. It is important to understand that TASTYLIA ORAL JELLY does not cause an erection without sexual stimulation, but only enhances the natural physiological reaction to arousal.

The drug is also prescribed to patients with symptoms of benign prostatic hyperplasia accompanied by urinary disorders. Tadalafil in TASTYLIA ORAL JELLY promotes the relaxation of the smooth muscle of the prostate and bladder neck, which facilitates urine outflow and reduces the severity of dysuric phenomena. In this case, the drug is used according to a special regimen determined by the doctor after a complete urological examination. The combination of efficacy regarding erectile dysfunction and prostate hyperplasia symptoms makes TASTYLIA ORAL JELLY a convenient choice for older men, in whom these conditions are often combined.

A separate category of patients to whom TASTYLIA ORAL JELLY may be recommended includes men with psychogenic erectile dysfunction associated with stress, anxiety, or performance anxiety syndrome. Due to the long duration of action of the drug, the patient is relieved of the need to plan medication intake immediately before sexual intercourse, which reduces psychological tension and allows focusing on intimate closeness. This approach contributes to breaking the pathological cycle of "anxiety — failure — increased anxiety" and the gradual restoration of self-confidence. In any case, before starting therapy, it is necessary to undergo an examination to rule out serious cardiovascular diseases, which may be a contraindication to the use of PDE-5 inhibitors.

Composition and active components of TASTYLIA ORAL JELLY

The active pharmaceutical ingredient of TASTYLIA ORAL JELLY is tadalafil at a dosage of 20 mg per sachet. Tadalafil belongs to selective inhibitors of the phosphodiesterase type 5 enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the cavernous bodies of the penis. By blocking this enzyme, tadalafil promotes the accumulation of cGMP, which leads to the relaxation of smooth muscle vascular fibers, dilation of arteries, and increased blood filling of the cavernous bodies. The result of this process is a firm erection that occurs only in the presence of sexual arousal, since it is stimulation that triggers the cascade of nitric oxide and cGMP formation.

Excipients of TASTYLIA ORAL JELLY include purified water, glycerin, sorbitol, flavorings, sweeteners, and stabilizers, which provide a gel-like consistency, pleasant taste, and long-term stability of the preparation. Glycerin acts as a humectant and prevents the jelly from drying out, while sorbitol is used as a sweetener, making the drug suitable for patients with diabetes mellitus. Flavorings give the product a pleasant fruity taste, which significantly improves patient compliance, especially those who have difficulty swallowing tablets. All excipients are of pharmaceutical purity and do not affect the therapeutic activity of the main component.

The mechanism of action of tadalafil in TASTYLIA ORAL JELLY differs from sildenafil and vardenafil by a longer duration of effect, which is due to the characteristics of its chemical structure and slower elimination from the body. The half-life of tadalafil is approximately 17.5 hours, which ensures the maintenance of therapeutic plasma concentration for 36 hours. This allows the patient not to tie the administration of the drug to a specific time of intimacy, which is a significant advantage in terms of quality of life. In addition, tadalafil demonstrates lower affinity for PDE-6 and PDE-11 isoenzymes compared to other representatives of the group, which reduces the risk of developing color vision disturbances and myalgias.

Dosage of TASTYLIA ORAL JELLY

The standard recommended dose of TASTYLIA ORAL JELLY for adult men is 20 mg of tadalafil, which corresponds to the contents of one sachet. The drug is used as needed, meaning it does not require daily administration unless the doctor has prescribed another therapeutic regimen. The maximum recommended frequency of administration is once a day, as exceeding this frequency does not increase efficacy but increases the probability of developing adverse reactions. For patients planning regular sexual activity, the doctor may suggest a daily administration regimen at a lower dose — 5 mg per day; however, this requires another dosage form, as TASTYLIA ORAL JELLY contains a fixed dose of 20 mg.

For elderly patients, dose adjustment of TASTYLIA ORAL JELLY is usually not required, as the pharmacokinetics of tadalafil does not change significantly with age. However, in men with impaired renal or hepatic function, a dose reduction or an increase in the interval between doses may be necessary, determined individually based on creatinine clearance and transaminase levels. In patients with severe renal failure, the use of tadalafil is contraindicated due to the risk of drug accumulation. With concomitant intake of CYP3A4 inhibitors, such as ketoconazole or ritonavir, the dose of TASTYLIA ORAL JELLY should be reduced to 10 mg, and the interval between doses increased to 72 hours.

The duration of the treatment course with TASTYLIA ORAL JELLY is determined by the doctor depending on the nature of the erectile dysfunction and the patient's response to therapy. In most cases, the drug is used as needed over a long period without developing tolerance or addiction. If, after several administration attempts, there is no effect, it is necessary to re-consult a doctor to review the diagnosis and possibly adjust the therapeutic strategy. It is important to remember that self-increasing the dose beyond the recommended one does not lead to an increased effect, but significantly increases the risk of developing serious adverse events, including priapism.

How to take TASTYLIA ORAL JELLY correctly?

TASTYLIA ORAL JELLY is taken orally by squeezing the contents of the sachet directly into the oral cavity followed by swallowing. The drug can be taken regardless of food intake, as the bioavailability of tadalafil does not depend on gastric fullness, unlike some other PDE-5 inhibitors. However, excessive consumption of high-fat food immediately before administration should be avoided, as this may slow down the absorption of the active component and delay the onset of effect. Taking TASTYLIA ORAL JELLY 30–60 minutes before planned sexual activity is considered optimal, although due to its long action, the drug can also be taken several hours before intimacy.

If a dose of TASTYLIA ORAL JELLY is missed when using the drug as needed, no special measures are required — it is sufficient to take the next dose when the need arises. If the patient follows a regular administration regimen, the missed dose should be taken as soon as possible, but the dose should not be doubled to compensate for the missed one. The contents of the sachet cannot be stored after opening, as the drug quickly loses stability upon contact with air and light. During therapy with TASTYLIA ORAL JELLY, it is recommended to abstain from consuming grapefruit juice, which can increase the concentration of tadalafil in the blood due to inhibition of cytochrome P450 enzymes.

Particular attention should be paid to the fact that TASTYLIA ORAL JELLY is not an aphrodisiac and does not cause sexual arousal by itself. To achieve a therapeutic effect, adequate sexual stimulation is required, as the drug only enhances the natural physiological response to erotic stimuli. Patients with cardiovascular diseases should undergo an examination before starting the drug to assess the ability to tolerate physical strain associated with sexual activity. If chest pain, dizziness, or nausea occur during intercourse, it is necessary to immediately stop the activity and seek medical assistance.

Side effects of TASTYLIA ORAL JELLY

The most common side effects of TASTYLIA ORAL JELLY are headache, dyspeptic phenomena, back and muscle pain, as well as facial flushing. Headache occurs due to vasodilation of brain vessels and is usually mild or moderate in nature, resolving on its own within a few hours. Dyspepsia manifests as a feeling of discomfort in the epigastric region, heartburn, or nausea, which is associated with the relaxation of the smooth muscle of the lower esophageal sphincter. Myalgias and back pain are a characteristic feature of tadalafil and usually occur 12–24 hours after administration, resolving within 48 hours.

Uncommon adverse reactions of TASTYLIA ORAL JELLY include dizziness, nasal congestion, palpitations, eyelid edema, eye pain, and increased photosensitivity. These symptoms are usually transient and do not require special treatment; however, if they recur or worsen, a doctor should be informed. Rare but potentially serious side effects are priapism — a prolonged painful erection lasting more than 4 hours, as well as sudden loss of vision or hearing. These conditions require immediate medical attention, as priapism without timely treatment can lead to irreversible damage to penile tissues and permanent impotence.

The body's individual reaction to TASTYLIA ORAL JELLY may differ depending on age, concomitant diseases, functional state of the liver and kidneys, as well as simultaneous intake of other medications. Patients should carefully monitor their well-being after the first administration of the drug and consult a doctor if any unusual symptoms appear. Most side effects are dose-dependent and decrease when reducing the dose or increasing the interval between doses. It is important not to self-medicate and not to take the drug without a prior medical examination, as erectile dysfunction can be an early marker of serious cardiovascular diseases.

Contraindications of TASTYLIA ORAL JELLY

An absolute contraindication to the use of TASTYLIA ORAL JELLY is the concomitant administration of nitrates in any dosage form, as the combination of tadalafil with nitric oxide donors can cause a critical drop in blood pressure up to the development of collapse. This applies both to drugs for the treatment of angina pectoris and to recreational agents containing amyl nitrite. The drug is also contraindicated in patients with hypersensitivity to tadalafil or any excipient, which may manifest as allergic reactions of varying severity. For men who have suffered a myocardial infarction within the last 90 days, a stroke within the last 6 months, or have unstable angina pectoris, the use of the drug is strictly prohibited.

Relative contraindications to taking TASTYLIA ORAL JELLY are severe hepatic impairment, end-stage renal failure with creatinine clearance less than 30 ml/min, as well as hypotension with blood pressure below 90/50 mmHg. The drug is not prescribed to patients with rare hereditary diseases associated with fructose intolerance, as sorbitol is part of the jelly. In men with penile deformations, such as Peyronie's disease, angiofibroma, or cavernosal fibrosis, the drug should be used with caution due to an increased risk of developing priapism. Caution is also required in conditions predisposing to priapism: sickle cell anemia, leukemia, multiple myeloma.

TASTYLIA ORAL JELLY is intended exclusively for men and is not used in women, children, and adolescents under 18 years of age. Studies on the safety and efficacy of tadalafil in these groups have not been conducted, so any use outside the approved indications is impermissible. The drug can be prescribed to elderly patients without dose adjustment; however, before starting therapy, it is necessary to carefully evaluate renal and cardiovascular function. Patients with retinitis pigmentosa should inform their doctor, as PDE-5 inhibitors can affect retinal function. Consultation with a doctor is mandatory before starting TASTYLIA ORAL JELLY to rule out hidden contraindications.

Interaction of TASTYLIA ORAL JELLY with other drugs and alcohol

TASTYLIA ORAL JELLY enters into clinically significant interactions with a number of medicinal products, which requires special attention during combination therapy. The most dangerous is the interaction with nitrates and nitric oxide donors, which can lead to fatal hypotension, so the simultaneous use of these drugs is absolutely prohibited. CYP3A4 inhibitors, such as ketoconazole, itraconazole, ritonavir, saquinavir, clarithromycin, and erythromycin, increase the plasma concentration of tadalafil, which requires reducing the dose of TASTYLIA ORAL JELLY to 10 mg and increasing the interval between doses. CYP3A4 inducers, in particular rifampicin, carbamazepine, and phenytoin, on the contrary, reduce the concentration of tadalafil, which may weaken its therapeutic effect.

Alcohol in moderate amounts does not enter into direct pharmacokinetic interaction with tadalafil; however, excessive consumption of alcoholic beverages can enhance orthostatic hypotension, dizziness, and headache. In addition, alcohol itself is a central nervous system depressant and can worsen erectile function, neutralizing the therapeutic effect of the drug. Patients taking TASTYLIA ORAL JELLY are recommended to limit alcohol consumption to a minimum or completely abstain from it on the days of taking the drug. Regarding driving vehicles, tadalafil can cause dizziness and visual impairment in individual patients, so until the individual reaction is clarified, one should refrain from driving a car and operating hazardous machinery.

Where to buy TASTYLIA ORAL JELLY in Ukraine

TASTYLIA ORAL JELLY is available in Ukrainian pharmacy chains, as well as in specialized online pharmacies that deliver medications throughout Ukraine. The drug is dispensed by prescription, so to purchase it, you must have an appropriate prescription confirming the diagnosis of erectile dysfunction and the absence of contraindications. This approach ensures patient safety and prevents uncontrolled use of the drug by individuals who do not require pharmacological correction. When purchasing, attention should be paid to the integrity of the packaging, expiration date, and the presence of protective elements confirming the originality of Healing Pharma products.

It is necessary to store TASTYLIA ORAL JELLY in its original packaging at a temperature not exceeding 25 degrees Celsius in a place protected from direct sunlight and inaccessible to children. The shelf life of the drug is usually 24 months from the date of manufacture, after which the use of the agent is strictly prohibited. Before starting to take TASTYLIA ORAL JELLY, it is mandatory to consult a doctor, as erectile dysfunction can be a symptom of serious diseases requiring complex treatment. Self-medication without establishing the exact cause of the disorder can mask the progression of the underlying pathology and delay necessary medical care.